Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
European Journal of Medicinal Chemistry|September 27, 2025
Design, synthesis, anticancer evaluation, biological screening, and computational study of novel 6,7-dimethoxyquinazoline derivatives as VEGFR-2 inhibitors and apoptotic inducersMostafa M A Aref, Abdallah E Abdallah, Mohammed A Dahab, et al.
The CRISPR Journal|November 20, 2019
Perspectives of Sickle Cell Disease Stakeholders on Heritable Genome EditingBrittany M Hollister, Mariclare C Gatter, Khadijah E Abdallah, et al.
International Journal of Molecular Sciences|August 12, 2023
Design, Synthesis, and Biological Evaluation of New Potential Unusual Modified Anticancer Immunomodulators for Possible Non-Teratogenic Quinazoline-Based Thalidomide AnalogsReda R Mabrouk, Abdallah E Abdallah, Hazem A Mahdy, et al.
Frontiers in Oncology|August 29, 2018
EBV Associated Breast Cancer Whole Methylome Analysis Reveals Viral and Developmental Enriched PathwaysMohammad O E Abdallah, Ubai K Algizouli, Maram A Suliman, et al.
Future Medicinal Chemistry|February 25, 2025
Novel triazoloquinazoline derivatives as VEGFR inhibitors: synthesis, cytotoxic evaluation and <i>in silico</i> studiesReda R Mabrouk, Hazem A Mahdy, Abdallah E Abdallah, et al.
Drug Design, Development and Therapy|March 14, 2022
New Series of VEGFR-2 Inhibitors and Apoptosis Enhancers: Design, Synthesis and Biological EvaluationAbdallah E Abdallah, Reda R Mabrouk, Mohamed R Elnagar, et al.
Molecules (Basel, Switzerland)|August 12, 2022
Modified Benzoxazole-Based VEGFR-2 Inhibitors and Apoptosis Inducers: Design, Synthesis, and Anti-Proliferative EvaluationAlaa Elwan, Abdallah E Abdallah, Hazem A Mahdy, et al.
Molecular Diversity|June 13, 2025
Quinazolinone based broad-spectrum antiviral molecules: design, synthesis, in silico studies and biological evaluationAbdallah E Abdallah, Omkulthom Al Kamaly, Esmail M El-Fakharany, et al.
Ecancermedicalscience|January 20, 2022
Clinico-pathological relationship between androgen receptor and tumour infiltrating lymphocytes in triple negative breast cancerHagar Elghazawy, Joaira Bakkach, Thanaa Helal, et al.
Pageof 10